1. Dimitroulas T, Douglas KM, Panoulas VF, Toms T, Smith JP, Treharne GJ, Nightingale P, Hodson J, Kitas GD (2013) Derangement of hemostasis in rheumatoid arthritis: association with demographic, inflammatory and metabolic factors. Clin Rheumatol 32:1357–1364
2. Doolittle RF (2012) Stanching the flow: The evolution of vertebrate blood clotting. University Science Books, Mill Valley, California
3. Fiusa MM, Carvalho-Filho MA, Annichino-Bizzacchi JM, De Paula EV (2015) Causes and consequences of coagulation activation in sepsis: an evolutionary medicine perspective. BMC Med 13:105–327
4. Gualtierotti R, Ingegnoli F, Griffini S, Grovetti E, Meroni PL, Cugno M (2016) Prothrombotic biomarkers in patients with rheumatoid arthritis: the beneficial effect of IL-6 receptor blockade. Clin Exp Rheumatol 34:451–458
5. Ingegnoli F, Fantini F, Griffini S, Soldi A, Meroni PL, Cugno M (2010) Anti-tumor necrosis factor alpha therapy normalizes fibrinolysis impairment in patients with active rheumatoid arthritis. Clin Exp Rheumatol 28:254–257